Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2020-06-11 2020-06-11
Drug Identification Number 02443112 02443112
Brand name ACT OLMESARTAN HCT ACT OLMESARTAN HCT
Common or Proper name OLMESARTAN/HCTZ 20/12.5MG FC TAB OLMESARTAN/HCTZ 20/12.5MG FC TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients OLMESARTAN MEDOXOMIL HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL HYDROCHLOROTHIAZIDE
Strength(s) 20MG 12.5MG 20MG 12.5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30's and 100's 30's and 100's
ATC code C09DA C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-06-08 2020-06-08
Remaining supply date 2020-06-08 2020-06-08
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments